Leveraging Omics Approaches to Identify and Select Highly Potent NK Cell Products

Time: 3:30 pm
day: Day One


  • Uncovering the source of heterogeneity in NK cells using transcriptomics and proteomics approaches
  • Identifying the biological differences of superior effectors, to produce more effective therapies
  • Applying signatures of superior donors to product development, with the future goal of identifying them as early as the stem cell stage